These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 16759099)

  • 1. Aminopyridine-based c-Jun N-terminal kinase inhibitors with cellular activity and minimal cross-kinase activity.
    Szczepankiewicz BG; Kosogof C; Nelson LT; Liu G; Liu B; Zhao H; Serby MD; Xin Z; Liu M; Gum RJ; Haasch DL; Wang S; Clampit JE; Johnson EF; Lubben TH; Stashko MA; Olejniczak ET; Sun C; Dorwin SA; Haskins K; Abad-Zapatero C; Fry EH; Hutchins CW; Sham HL; Rondinone CM; Trevillyan JM
    J Med Chem; 2006 Jun; 49(12):3563-80. PubMed ID: 16759099
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Discovery of CC-930, an orally active anti-fibrotic JNK inhibitor.
    Plantevin Krenitsky V; Nadolny L; Delgado M; Ayala L; Clareen SS; Hilgraf R; Albers R; Hegde S; D'Sidocky N; Sapienza J; Wright J; McCarrick M; Bahmanyar S; Chamberlain P; Delker SL; Muir J; Giegel D; Xu L; Celeridad M; Lachowitzer J; Bennett B; Moghaddam M; Khatsenko O; Katz J; Fan R; Bai A; Tang Y; Shirley MA; Benish B; Bodine T; Blease K; Raymon H; Cathers BE; Satoh Y
    Bioorg Med Chem Lett; 2012 Feb; 22(3):1433-8. PubMed ID: 22244937
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel 3,6-Disubstituted Pyridazine Derivatives Targeting JNK1 Pathway: Scaffold Hopping and Hybridization-Based Design, Synthesis, Molecular Modeling, and
    Shaalan MM; Osman EEA; Attia YM; Hammam OA; George RF; Naguib BH
    ACS Omega; 2024 Sep; 9(35):37310-37329. PubMed ID: 39246493
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhancing SILCS-MC via GPU Acceleration and Ligand Conformational Optimization with Genetic and Parallel Tempering Algorithms.
    Zhao M; Yu W; MacKerell AD
    J Phys Chem B; 2024 Aug; 128(30):7362-7375. PubMed ID: 39031121
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TGFβ1-driven SMAD2/3 phosphorylation and myofibroblast emergence are fully dependent on the TGFβ1 pre-activation of MAPKs and controlled by maternal leucine zipper kinase.
    Wang Z; Castro N; Bernstein AM; Wolosin JM
    Cell Signal; 2024 Jan; 113():110963. PubMed ID: 37931692
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MM/PB(GB)SA benchmarks on soluble proteins and membrane proteins.
    Wang S; Sun X; Cui W; Yuan S
    Front Pharmacol; 2022; 13():1018351. PubMed ID: 36532746
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Best practices for constructing, preparing, and evaluating protein-ligand binding affinity benchmarks [Article v0.1].
    Hahn DF; Bayly CI; Macdonald HEB; Chodera JD; Mey ASJS; Mobley DL; Benito LP; Schindler CEM; Tresadern G; Warren GL
    Living J Comput Mol Sci; 2022; 4(1):. PubMed ID: 36382113
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessing the effect of forcefield parameter sets on the accuracy of relative binding free energy calculations.
    Sun S; Huggins DJ
    Front Mol Biosci; 2022; 9():972162. PubMed ID: 36225254
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fenretinide combines perturbation of signaling kinases, cell-extracellular matrix interactions and matrix metalloproteinase activation to inhibit invasion in oral squamous cell carcinoma cells.
    Wang D; Pei P; Shea FF; Bissonnette C; Nieto K; Din C; Liu Y; Schwendeman SP; Lin YX; Spinney R; Mallery SR
    Carcinogenesis; 2022 Oct; 43(9):851-864. PubMed ID: 35974187
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel c-Jun N-Terminal Kinase (JNK) Inhibitors with an 11
    Liakhov SA; Schepetkin IA; Karpenko OS; Duma HI; Haidarzhy NM; Kirpotina LN; Kovrizhina AR; Khlebnikov AI; Bagryanskaya IY; Quinn MT
    Molecules; 2021 Sep; 26(18):. PubMed ID: 34577159
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Data Mining and Systems Pharmacology to Elucidate Effectiveness and Mechanisms of Chinese Medicine in Treating Primary Liver Cancer.
    Zhang Z; Li JW; Zeng PH; Gao WH; Tian XF
    Chin J Integr Med; 2022 Jul; 28(7):636-643. PubMed ID: 34432201
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mutations in the transcription factor FOXO1 mimic positive selection signals to promote germinal center B cell expansion and lymphomagenesis.
    Roberto MP; Varano G; Vinas-Castells R; Holmes AB; Kumar R; Pasqualucci L; Farinha P; Scott DW; Dominguez-Sola D
    Immunity; 2021 Aug; 54(8):1807-1824.e14. PubMed ID: 34380064
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Endoplasmic reticulum stress causes insulin resistance by inhibiting delivery of newly synthesized insulin receptors to the cell surface.
    Brown M; Dainty S; Strudwick N; Mihai AD; Watson JN; Dendooven R; Paton AW; Paton JC; Schröder M
    Mol Biol Cell; 2020 Nov; 31(23):2597-2629. PubMed ID: 32877278
    [TBL] [Abstract][Full Text] [Related]  

  • 14. C-Jun N-terminal kinase inhibitors: Structural insight into kinase-inhibitor complexes.
    Duong MTH; Lee JH; Ahn HC
    Comput Struct Biotechnol J; 2020; 18():1440-1457. PubMed ID: 32637042
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The JNK Signaling Pathway in Inflammatory Skin Disorders and Cancer.
    Hammouda MB; Ford AE; Liu Y; Zhang JY
    Cells; 2020 Apr; 9(4):. PubMed ID: 32252279
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Discovery of 1-Pyrimidinyl-2-Aryl-4,6-Dihydropyrrolo [3,4-d]Imidazole-5(1
    Jang M; Oh Y; Cho H; Yang S; Moon H; Im D; Hah JM
    Int J Mol Sci; 2020 Mar; 21(5):. PubMed ID: 32131443
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sampling Conformational Changes of Bound Ligands Using Nonequilibrium Candidate Monte Carlo and Molecular Dynamics.
    Sasmal S; Gill SC; Lim NM; Mobley DL
    J Chem Theory Comput; 2020 Mar; 16(3):1854-1865. PubMed ID: 32058713
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Discovery of 3-alkyl-5-aryl-1-pyrimidyl-1
    Oh Y; Jang M; Cho H; Yang S; Im D; Moon H; Hah JM
    J Enzyme Inhib Med Chem; 2020 Dec; 35(1):372-376. PubMed ID: 31856610
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Conformational restriction of a type II FMS inhibitor leading to discovery of 5-methyl-
    Im D; Moon H; Kim J; Oh Y; Jang M; Hah JM
    J Enzyme Inhib Med Chem; 2019 Dec; 34(1):1716-1721. PubMed ID: 31571509
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cytokine production in myelofibrosis exhibits differential responsiveness to JAK-STAT, MAP kinase, and NFκB signaling.
    Fisher DAC; Miner CA; Engle EK; Hu H; Collins TB; Zhou A; Allen MJ; Malkova ON; Oh ST
    Leukemia; 2019 Aug; 33(8):1978-1995. PubMed ID: 30718771
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.